Varenicline – Medxy AI

Optimizing Nurse-Led Smoking Cessation: Insights from a Systematic Review and Network Meta-Analysis

By MedXY 10/12/2025

Nurse-led interventions, especially intensive counseling combined with varenicline or family-based approaches, significantly enhance smoking cessation rates. Brief advice and counseling also improve outcomes over usual care, supporting nurses' vital role in tobacco cessation.

Clinical Updates news Psychiatry Specialties

Optimizing Smoking Cessation in Major Depressive Disorder: Varenicline Outperforms Bupropion and Nicotine Patch with Comparable Safety

By MedXY 08/28/2025

This analysis reveals that varenicline is the most effective and safe pharmacotherapy for smoking cessation in individuals with current or past major depressive disorder, outperforming bupropion and nicotine patches with no increased neuropsychiatric risks.

Clinical Updates Pediatrics Public Health Specialties

Varenicline Significantly Enhances Nicotine Vaping Cessation in Youth: Insights from a Landmark Randomized Clinical Trial

By MedXY 08/25/2025

A randomized clinical trial demonstrates that varenicline, combined with behavioral counseling, markedly improves nicotine vaping cessation rates in youth aged 16-25 who vape daily and do not regularly smoke tobacco.